Literature DB >> 11408027

Typical antipsychotics exhibit inverse agonist activity at rat dopamine D1-like receptors expressed in Sf9 cells.

M W Martin1, A W Scott, D E Johnston, S Griffin, R R Luedtke.   

Abstract

The baculovirus system has been used to express the rat dopamine D1 receptors in Spodoptera frugiperda (Sf9) cells. A panel of typical antipsychotics including, alpha-flupenthixol, fluphenazine and thioridizine were found to inhibit dopamine-dependent stimulation of adenylyl cyclase. However, these compounds were also found to inhibit adenylyl cyclase activity in the absence of agonist in Sf9 cells expressing dopamine D1-like receptors. Therefore, these nonselective dopamine receptor compounds displayed negative intrinsic or inverse agonist activity. None of the compounds tested were neutral antagonists.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408027     DOI: 10.1016/s0014-2999(01)00982-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Inhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease.

Authors:  Jonathan Chetrit; Anne Taupignon; Lionel Froux; Stephanie Morin; Rabia Bouali-Benazzouz; Frédéric Naudet; Nabila Kadiri; Christian E Gross; Bernard Bioulac; Abdelhamid Benazzouz
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

2.  Constitutive activity of dopamine receptor type 1 (D1R) increases CaV2.2 currents in PFC neurons.

Authors:  Clara Inés McCarthy; Cambria Chou-Freed; Silvia Susana Rodríguez; Agustín Yaneff; Carlos Davio; Jesica Raingo
Journal:  J Gen Physiol       Date:  2020-05-04       Impact factor: 4.086

Review 3.  The vital role of constitutive GPCR activity in the mesolimbic dopamine system.

Authors:  F J Meye; G M J Ramakers; R A H Adan
Journal:  Transl Psychiatry       Date:  2014-02-11       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.